How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few & Far Between podcast, host Marc Gas, PhD, welcomes Kelly Franchetti, RN, SVP at YPrime, to discuss where advocacy is headed and where it needs to go.
How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far...
Today on the Biorasi Few & Far Between podcast: Join new host Melissa Alesse and former host Chris O'Brien - CEO at Rancho BioSciences...
"So we built the seatbelts before the car, so to speak, wherein we did a project to figure out ways to biocontain these organisms....